| 產(chǎn)品名稱 | Iniparib - BSI 201 |
| 產(chǎn)品貨號 | Axon 1566 CAS [160003-66-7] MF C7H5IN2O3MW 292.03 Purity: 99% Soluble in DMSO Description An irreversible inhibitor of poly(ADP-ribose) polymerase-1 (PARP 1); it inhibits PARP1, a nuclear enzyme that promotes DNA repair through the base-excision repair pathway; potential therapeutic undergoing clinical trials for treatment of some types of breast cancer References Certificates Categories Extra info A Patel and SH Kaufmann. Development of PARP Inhibitors: An Unfinished Story. ONCOLOGY. 2010, Vol. 24 No. 1.? ? J O'Shaughnessy et al. Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer. N. Engl. J. Med. 2011, 364, 205-214. ? LA Carey and NE Sharpless. PARP and Cancer — If It's Broke, Don't Fix It. N. Engl. J. Med. 2011, 364, 277-279. Certificate of Analysis Material Safety Data Sheet Cell Cycle Regulation Cell Signaling & Oncology Epigenetics DNA-damage Response EC 2.4.2.30 PARP PARP inhibitor Chemical name 4-iodo-3-nitrobenzamide Parent CAS No. [160003-66-7] Order Size Unit Price Stock 10 mg €65.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Iniparib - BSI 201Axon 1566 CAS [160003-66-7] MF C7H5IN2O3
Description
An irreversible inhibitor of poly(ADP-ribose) polymerase-1 (PARP 1); it inhibits PARP1, a nuclear enzyme that promotes DNA repair through the base-excision repair pathway; potential therapeutic undergoing clinical trials for treatment of some types of breast cancer
PARP inhibitor
Chemical name4-iodo-3-nitrobenzamide Parent CAS No.[160003-66-7] |
| 產(chǎn)品資料 |
